Janus Henderson Group
BEAM icon

Janus Henderson Group’s Beam Therapeutics BEAM Stock Holding History

Janus Henderson Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22M Buy
93,253
+53,752
+136% +$1.49M ﹤0.01% 1296
2025
Q4 		$1.09M Hold
39,501
– – ﹤0.01% 1624
2025
Q3 		$959K Hold
39,501
– – ﹤0.01% 1689
2025
Q2 		$672K Sell
39,501
-1,712,901
-98% -$29.8M ﹤0.01% 1799
2025
Q1 		$38.9M Buy
1,752,402
+1,719,901
+5,292% +$45.1M 0.02% 431
2024
Q4 		$806K Sell
32,501
-4,500
-12% -$115K ﹤0.01% 1799
2024
Q3 		$907K Hold
37,001
– – ﹤0.01% 1722
2024
Q2 		$867K Buy
37,001
+9,815
+36% +$241K ﹤0.01% 1695
2024
Q1 		$897K Buy
27,186
+12
+0% +$374 ﹤0.01% 1696
2023
Q4 		$739K Sell
27,174
-54
-0.2% -$1.34K ﹤0.01% 1806
2023
Q3 		$655K Buy
27,228
+76
+0.3% +$2.04K ﹤0.01% 1787
2023
Q2 		$867K Sell
27,152
-77
-0.3% -$2.5K ﹤0.01% 1677
2023
Q1 		$833K Buy
27,229
+13,650
+101% +$539K ﹤0.01% 1731
2022
Q4 		$531K Sell
13,579
-6,961
-34% -$312K ﹤0.01% 1688
2022
Q3 		$978K Buy
20,540
+8,383
+69% +$478K ﹤0.01% 1655
2022
Q2 		$471K Buy
12,157
+5,804
+91% +$231K ﹤0.01% 1807
2022
Q1 		$364K Buy
+6,353
New +$417K ﹤0.01% 2104

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Janus Henderson Group's BEAM Position: Q1 2026 in Review

Janus Henderson Group increased its Beam Therapeutics (BEAM) stake by 136% in Q1 2026, buying an estimated $1.49M and bringing the position to 93,253 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1296.

Janus Henderson Group first reported a position in BEAM in Q1 2022 and has held it in 17 quarters since. The position peaked at $38.9M in Q1 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Janus Henderson Group held 93,253 shares of Beam Therapeutics worth $2.22M as of Q1 2026.
  • Janus Henderson Group bought 53,752 Beam Therapeutics shares in Q1 2026, an estimated $1.49M.
  • Beam Therapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1296 holding.
  • Janus Henderson Group first reported a position in Beam Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Janus Henderson Group's Beam Therapeutics position peaked at $38.9M in Q1 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.